Justices Won't Review Janssen's Liability For Risperdal Death
A California appellate court's decision that Janssen Pharmaceuticals can't be blamed for a doctor's error during a clinical trial for the antipsychotic medication Risperdal will hold up, after the U.S. Supreme Court...To view the full article, register now.
Already a subscriber? Click here to view full article